- Viking Therapeutics priced 7.9 million shares at $35 per share in a common stock offering.
Shares of Viking Therapeutics (VKTX) dropped 12% premarket after the company priced an upsized common stock and convertible note offering. The offerings were increased from the original $200 million each to a larger deal, adding dilution and debt. Settlement is set for Friday.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.